Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Yusef Manufacturing Laboratories, LLC
WARNING LETTER
•Yusef Manufacturing Laboratories, LLC•September 24, 2021

Yusef Manufacturing Laboratories, LLC – FDA Warning Letter, Sep 24, 2021

Record Details

The FDA issued a Warning Letter to Yusef Manufacturing Laboratories, LLC, following an inspection from September 20-24, 2021, identifying significant Current Good Manufacturing Practice (CGMP) violations for finished pharmaceuticals, rendering their drug products adulterated.

Key violations include: 1. **Failure to test components:** The firm did not adequately test incoming components, like ethanol for hand sanitizers, for identity, purity, strength, or quality, relying on unqualified supplier COAs. For example, ethanol was accepted based only on color, odor, and appearance, despite the supplier's COA stating it was not for drug manufacturing. 2. **Inadequate OOS investigations:** Investigations into out-of-specification (OOS) laboratory results were incomplete, lacked scientific conclusions, and had insufficient corrective and preventive actions (CAPA). An SPF30 Lip Balm Sunscreen batch with failing API assay results was released after retesting without a thorough investigation into the manufacturing process. 3. **Insufficient laboratory controls:** The firm lacked suitable analytical instrumentation and test methods for hand sanitizer assay, active ingredient identity, and impurity limits (e.g., methanol). Microbiological test methods for water and finished products were not demonstrated as suitable, and growth promotion testing for media was not conducted. 4. **Lack of process validation:** Manufacturing processes were not adequately validated to ensure reproducibility and consistent drug quality. 5. **Inadequate stability program:**

Company
Yusef Manufacturing Laboratories, LLC
Inspection date
September 24, 2021
Product type
Drugs
Office
Division of Pharmaceutical Quality Operations IV
People
  • Lance M. De Souza (Director - Compliance Branch)
  • Steven E. Porter (Program Division Director)
  • Bryan A. Galvez (Pharmaceutical investigator)
View Company Profile

ID · 69895fef-af1c-42b3-803d-9eda24f47e48

Violation Codes9
21 CFR 21021 CFR 21121 CFR 211.84(d)(1)21 CFR 211.84(d)(2)21 CFR 211.19221 CFR 211.160(b)21 CFR 211.100(a)21 CFR 211.166(a)21 U.S.C. 351(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Other documents for Yusef Manufacturing Laboratories, LLC
  • 483 - 2022-11-04November 4, 2022
  • 483 - 2021-09-24September 24, 2021
  • 483 - 2019-09-13September 13, 2019
  • 483 - 2016-05-26May 26, 2016

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Yusef Manufacturing Laboratories, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.